On the proton conductivity of Nafion-Faujasite composite membranes for low temperature direct methanol fuel cells

Although zeolites are introduced to decrease methanol crossover of Nafion membranes for direct methanol fuel cells (DMFCs), little is known about the effect of their intrinsic properties and the interaction with the ionomer. In this work, Nafion-Faujasite composite membranes prepared by solution casting were characterized by extensive physicochemical and electrochemical techniques. Faujasite was found to undergo severe dealumination during the membrane activation, but its structure remained intact. The zeolite interacts with Nafion probably through hydrogen bonding between Si-OH and SO₃H groups, which combined with the increase of the water uptake and the water mobility, and the addition of a less conductive phase (the zeolite) leads to an optimum proton conductivity between 0.98 and 2 wt% of zeolite. Hot pressing the membranes before their assembling with the electrodes enhanced the DMFC performance by reducing the methanol crossover and the serial resistance.     

Carbon nanotubes/polydimethylsiloxanes systems for thermal management of miniaturized electronic components

The thermal performances of nanocomposite layers formed by Single-walled Carbon Nanotubes (SWCNT) dispersed in 2 different kind of polydimethyl-siloxane (PDMSO) matrices has been investigated by measuring the thermal resistance under conditions similar to the ones used for thermal management in microelectronics. A series of nanocomposite samples with thickness in the range 25 microm(-1) cm have been tested. The nanocomposites were prepared varying the amounts of nanotubes embedded in the matrix (from 0.1 to 5%w). In some cases also microsized graphites were mixed to the nanotube's fillers. For 25 micron thick layers, the thermal resistance of the neat silicone specimen can be reduced of 54% with the addition of 2%w carbon nanotubes. The variation of thermal conductivity as a function of the SWCNT's loading is reported and discussed. Furthermore the dispersion's effects of the nanotubes in the layers and the effects on the realization of a net-like system have been investigated.     

New insights on the consolidation of salt weathered limestone: the case study of Modica stone

Bulletin of Engineering Geology and the Environment - The deterioration of a stone material is related to its pore structure, which affects the interaction between surface and environmental agents....     

Residue analysis of thyreostats in baby foods via matrix solid phase dispersion and liquid chromatography – dual-polarity electrospray – tandem mass spectrometry

This paper describes a rapid method for confirming residues of thyreostats in meat-based baby foods by using liquid chromatography – dual polarity electrospray – tandem mass spectrometry (LC-ES(±)-MS/MS). Six thioureylenes, belonging to the group of thiouracil and imidazole, were selected for this work: thiouracil (TU), methylthiouracil (MTU), propylthiouracil (PTU), phenylthiouracil (PhTU), mercaptobenzimidazole (MBI) and tapazole (TAP).

The amphoteric nature of these compounds allows their electrospray detection in both positive and negative ionisation. Nevertheless, MS detection is not favoured by their low molecular weights, while their chromatographic retention is also thwarted by their high polarity. A pentafluorophenyl (PFP) core-shell phase column was selected to avoid peak asymmetry or peak splitting, and a dual-polarity ionisation method was optimised to obtain a sensitivity as high as possible. The method was validated according to the Commission Decision 657/2002/EC. A simple and fast procedure based on matrix solid phase dispersion (MSPD) was optimised to extract analytes from baby foods with recoveries exceeding 82%. Limit of decision (CCα) and detection capability (CCβ) were lower than the permissible maximum concentration (10 ng g^?1). The validated method was then applied to assess the potential occurrence of the six selected thyreostats in nine commercial products. All the samples were found free of contamination.     

Crystallographic Texture Evolution of a Zinc Sheet Subjected to Different Strain Paths

Metallurgical and Materials Transactions A - The use of zinc sheets has largely increased in the last years, fundamentally because of new tendencies in architecture and, at the same time, due to...     

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia

The C-terminal aminoacidic sequence from NPM1-mutated protein, absent in normal human tissues, may serve as a leukemia-specific antigen and can be considered an ideal target for NPM1-mutated acute myeloid leukemia (AML) immunotherapy. Different in silico instruments and in vitro/ex vivo immunological platforms have identified the most immunogenic epitopes from NPM1-mutated protein. Spontaneous development of endogenous NPM1-mutated-specific cytotoxic T cells has been observed in patients, potentially contributing to remission maintenance and prolonged survival. Genetically engineered T cells, namely CAR-T or TCR-transduced T cells, directed against NPM1-mutated peptides bound to HLA could prospectively represent a promising therapeutic approach. Although either adoptive or vaccine-based immunotherapies are unlikely to be highly effective in patients with full-blown leukemia, these strategies, potentially in combination with immune-checkpoint inhibitors, could be promising in maintaining remission or preemptively eradicating persistent measurable residual disease, mainly in patients ineligible for allogeneic hematopoietic stem cell transplant (HSCT). Alternatively, neoantigen-specific donor lymphocyte infusion derived from healthy donors and targeting NPM1-mutated protein to selectively elicit graft-versus-leukemia effect may represent an attractive option in subjects experiencing post-HSCT relapse. Future studies are warranted to further investigate dynamics of NPM1-mutated-specific immunity and explore whether novel individualized immunotherapies may have potential clinical utility in NPM1-mutated AML patients.